CY2494B1 - Cephalosporin synthesis. - Google Patents

Cephalosporin synthesis.

Info

Publication number
CY2494B1
CY2494B1 CY0400084A CY0400084A CY2494B1 CY 2494 B1 CY2494 B1 CY 2494B1 CY 0400084 A CY0400084 A CY 0400084A CY 0400084 A CY0400084 A CY 0400084A CY 2494 B1 CY2494 B1 CY 2494B1
Authority
CY
Cyprus
Prior art keywords
denotes
hydrogen
group
silyl group
denote
Prior art date
Application number
CY0400084A
Other languages
English (en)
Inventor
Gerd Ascher
Johannes Ludescher
Hubert Sturm
Josef Wieser
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AT0085894A external-priority patent/AT402072B/de
Priority claimed from AT85794A external-priority patent/AT402927B/de
Priority claimed from AT0106694A external-priority patent/AT402929B/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CY2494B1 publication Critical patent/CY2494B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cephalosporin Compounds (AREA)
CY0400084A 1994-04-25 2004-11-24 Cephalosporin synthesis. CY2494B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT0085894A AT402072B (de) 1994-04-25 1994-04-25 Cephemderivate und verfahren zu ihrer herstellung
AT85794A AT402927B (de) 1994-04-25 1994-04-25 Neue cefalosporinderivate, verfahren zu ihrer herstellung und ihre verwendung
AT0106694A AT402929B (de) 1994-05-25 1994-05-25 Neue cephalosporinderivate, verfahren zu ihrer herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
CY2494B1 true CY2494B1 (en) 2005-09-02

Family

ID=27146806

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0400084A CY2494B1 (en) 1994-04-25 2004-11-24 Cephalosporin synthesis.

Country Status (26)

Country Link
US (4) US5856474A (cs)
EP (2) EP0757691B1 (cs)
JP (1) JP3302369B2 (cs)
KR (1) KR100487833B1 (cs)
CN (3) CN1145629C (cs)
AT (2) ATE498627T1 (cs)
AU (1) AU686380B2 (cs)
BR (1) BR9507512A (cs)
CA (2) CA2533837A1 (cs)
CY (1) CY2494B1 (cs)
CZ (1) CZ297565B6 (cs)
DE (2) DE69536140D1 (cs)
DK (1) DK0757691T3 (cs)
ES (1) ES2202362T3 (cs)
FI (1) FI963761L (cs)
HU (3) HUT75229A (cs)
MX (1) MX9604353A (cs)
NO (1) NO318020B1 (cs)
NZ (2) NZ285084A (cs)
PL (2) PL184773B1 (cs)
PT (1) PT757691E (cs)
RU (2) RU2225411C2 (cs)
SI (1) SI0757691T1 (cs)
SK (1) SK285948B6 (cs)
TW (1) TW427992B (cs)
WO (1) WO1995029182A1 (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248881B1 (en) * 1991-03-08 2001-06-19 Biochemie Gmbh Intermediates and process for the production of 3-vinyl cephalosporins
US5856474A (en) * 1994-04-25 1999-01-05 Biochemie Gesellschaft, M.B.H. Cephalosporin synthesis
EP1067131B1 (en) * 1999-07-05 2007-08-15 Basilea Pharmaceutica AG New process for the manufacture of cephalosporin derivatives
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US7527807B2 (en) * 2000-06-21 2009-05-05 Cubist Pharmaceuticals, Inc. Compositions and methods for increasing the oral absorption of antimicrobials
KR20080056308A (ko) 2000-06-21 2008-06-20 큐비스트 파마슈티컬즈 인코포레이티드 항미생물제의 경구 흡수를 개선하기 위한 조성물 및 방법
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US8313776B2 (en) 2003-07-21 2012-11-20 Shionogi Inc. Antibiotic product, use and formulation thereof
EP1648418A4 (en) 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
US8313775B2 (en) 2003-07-21 2012-11-20 Shionogi Inc. Antibiotic product, use and formulation thereof
AU2004264939A1 (en) 2003-08-11 2005-02-24 Middlebrook Pharmaceuticals, Inc. Robust pellet
EP1653924A4 (en) 2003-08-12 2009-09-09 Middlebrook Pharmaceuticals In ANTIBIOTICS, USE AND FORMULATION ASSOCIATED
AU2004270170B2 (en) 2003-08-29 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP2007513869A (ja) 2003-09-15 2007-05-31 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
EP1771158A4 (en) 2004-07-02 2008-03-12 Advancis Pharmaceutical Corp TABLET FOR PULSE DISTRIBUTION
NZ580951A (en) * 2005-04-29 2011-06-30 Cubist Pharm Inc Therapeutic compositions
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
JP2012528102A (ja) 2009-05-25 2012-11-12 サンド・アクチエンゲゼルシヤフト セフトビプロールメドカリルの製造方法
ITMI20131820A1 (it) 2013-11-04 2015-05-05 Laboratorio Chimico Int Spa Procedimento per la preparazione di olopatadina
CN109180704B (zh) * 2018-11-19 2020-06-05 齐鲁安替制药有限公司 一种头孢妥仑匹酯的合成方法
EP4025577A1 (en) 2019-09-06 2022-07-13 Nabriva Therapeutics GMBH Siderophore cephalosporin conjugates and uses thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3351596A (en) * 1966-09-21 1967-11-07 Lilly Co Eli 3-formyl cephalosporins
US3769277A (en) 1970-01-23 1973-10-30 Glaxo Lab Ltd Preparation of delta3-4 carboxy cephalosporins having a 3-vinyl or substituted 3-vinyl group
CH556876A (de) * 1971-05-19 1974-12-13 Ciba Geigy Ag Verfahren zur herstellung von cephalosporansaeurederivaten.
CH546794A (de) * 1970-06-18 1974-03-15 Ciba Geigy Ag Verfahren zur herstellung von cephalosporansaeurederivaten.
US3674784A (en) * 1970-07-27 1972-07-04 Lilly Co Eli 3-formyl cephalosporin sulfoxides
GB1368231A (en) * 1970-07-31 1974-09-25 Glaxo Lab Ltd Thio-substituted azetidinones and thiazolino azetidinones
US3880851A (en) * 1971-12-24 1975-04-29 Lilly Co Eli Antibiotic method
CA1109860A (en) * 1972-12-08 1981-09-29 Shinji Terao Process for producing lactol-type cephalosporins
JPS49109391A (cs) * 1973-02-28 1974-10-17
JPS5093989A (cs) * 1973-10-25 1975-07-26
JPS5071691A (cs) * 1973-11-02 1975-06-13
JPS5129492A (en) * 1974-09-04 1976-03-12 Sankyo Co Sefuarosuhorinjudotai no seiho
GB1447959A (en) * 1975-02-27 1976-09-02 Shionogi & Co Process for preparing cephem aldehyde derivatives
US4101658A (en) * 1975-06-04 1978-07-18 Shionogi & Co., Ltd. Antibacterial hydrazono cephalosporins
GB8821797D0 (en) * 1988-09-16 1988-10-19 Beecham Group Plc Novel compounds
US5081116A (en) 1989-04-12 1992-01-14 Yamanouchi Pharmaceutical Co., Ltd. Cephalosporin derivatives
JP2895900B2 (ja) * 1990-03-08 1999-05-24 大塚化学株式会社 3―ホルミルセフエム誘導体の製造法
AT400436B (de) * 1992-11-10 1995-12-27 Biochemie Gmbh Neues verfahren zur herstellung von 3-vinylcephalosporinverbindungen
ES2157199T3 (es) * 1991-03-08 2001-08-16 Biochemie Gmbh Nuevo procedimiento para la produccion de cefalosporinas y nuevos compuestos intermedios para este procedimiento.
ES2185634T3 (es) 1993-04-16 2003-05-01 Basilea Pharmaceutica Ag Derivados de cefalosporina.
US5856474A (en) * 1994-04-25 1999-01-05 Biochemie Gesellschaft, M.B.H. Cephalosporin synthesis

Also Published As

Publication number Publication date
JPH09512259A (ja) 1997-12-09
SK285948B6 (sk) 2007-11-02
JP3302369B2 (ja) 2002-07-15
AU2407295A (en) 1995-11-16
DE69531203D1 (en) 2003-08-07
EP0757691B1 (en) 2003-07-02
EP1340762A1 (en) 2003-09-03
FI963761A7 (fi) 1996-09-20
CA2533837A1 (en) 1995-11-02
BR9507512A (pt) 1997-09-02
KR970702284A (ko) 1997-05-13
KR100487833B1 (ko) 2005-10-14
US6093813A (en) 2000-07-25
HU9602940D0 (en) 1996-12-30
WO1995029182A1 (en) 1995-11-02
TW427992B (en) 2001-04-01
SK135796A3 (en) 1997-05-07
FI963761A0 (fi) 1996-09-20
RU2150471C1 (ru) 2000-06-10
NZ329984A (en) 1998-06-26
ATE498627T1 (de) 2011-03-15
CN1146770A (zh) 1997-04-02
PT757691E (pt) 2003-11-28
CZ297565B6 (cs) 2007-02-07
DE69531203T2 (de) 2004-04-22
HU0102726D0 (en) 2001-08-28
SI0757691T1 (en) 2003-12-31
DE69536140D1 (de) 2011-03-31
US5856474A (en) 1999-01-05
EP0757691A1 (en) 1997-02-12
US6034237A (en) 2000-03-07
PL184773B1 (pl) 2002-12-31
NZ285084A (en) 1998-05-27
CA2180829A1 (en) 1995-11-02
HU0102725D0 (en) 2001-08-28
CZ310696A3 (en) 1997-01-15
MX9604353A (es) 1997-06-28
CN1145628C (zh) 2004-04-14
NO964493D0 (no) 1996-10-23
CN1092662C (zh) 2002-10-16
PL316661A1 (en) 1997-02-03
PL182864B1 (pl) 2002-03-29
HUT75229A (en) 1997-04-28
EP1340762B1 (en) 2011-02-16
ES2202362T3 (es) 2004-04-01
CN1145629C (zh) 2004-04-14
CN1326935A (zh) 2001-12-19
RU2225411C2 (ru) 2004-03-10
CN1344720A (zh) 2002-04-17
AU686380B2 (en) 1998-02-05
CA2180829C (en) 2008-06-03
NO318020B1 (no) 2005-01-24
DK0757691T3 (da) 2003-10-27
NO964493L (no) 1996-10-23
ATE244247T1 (de) 2003-07-15
US6063917A (en) 2000-05-16
FI963761L (fi) 1996-09-20

Similar Documents

Publication Publication Date Title
CY2494B1 (en) Cephalosporin synthesis.
EP0592677A4 (en) -g(b)-lactam compound and cephem compound, and production thereof
CA2324959A1 (en) Phthalimido compounds as intermediates for producing substance p receptor antagonists
FI853737L (fi) Foerfarande foer framstaellning av optiskt aktiva acyloxiazetidinoner.
ZA93267B (en) Novel arylcyloakyl derivatives their production and their use
ATE181066T1 (de) Zwischenverbindungen zur herstellung von thioalkylthio cephalosporinderivaten
CA2103072A1 (en) Pleuromutilin derivatives
AU2740992A (en) Dental cement
IE840230L (en) Azetidinones.
GR3036405T3 (en) Novel intermediate for synthetic use and process for producing aminopiperazine derivative
TW277059B (cs)
EP0837066A4 (en) IMPROVED METHOD FOR PRODUCING PENICILLIN G PHENYL ESTER
DE3269494D1 (en) Novel intermediates and process for preparing (s)-3-acylamino-4-substituted-2-azetidinones
GB8614710D0 (en) Process
TW239123B (cs)
ES8203379A1 (es) Un procedimiento para la preparacion de carbapenemas